Galea Life Sciences, Inc. Accepts Settlement and Prepares New Form 10 Registration Statement
October 09, 2008 08:00 ET
|
Galea Life Sciences
MIAMI, Oct. 9, 2008 (GLOBE NEWSWIRE) -- Galea Life Sciences Inc. (Pink Sheets:GLSN) announced today that the company has accepted an offer of settlement with the U.S. Securities and Exchange...
Galea Life Sciences' Subsidiary Awarded Presentation Slot for Clinical Policy Abstract At 15th International Symposium on HIV and Emerging Infectious Diseases
April 01, 2008 09:00 ET
|
Galea Life Sciences
MIAMI, April 1, 2008 (PRIME NEWSWIRE) -- Galea Life Sciences, Inc. (Pink Sheets:GLSN) announced that its BioSource Therapeutics, Inc. (BST) subsidiary will present its clinical policy abstract...
Galea Life Sciences, Inc. Completes Financing
March 06, 2008 11:16 ET
|
Galea Life Sciences
MIAMI, March 6, 2008 (PRIME NEWSWIRE) -- Galea Life Sciences, Inc. (Pink Sheets:GLSN), whose BioSource Therapeutics, Inc. (BST) subsidiary manufactures and markets Nutraplete(tm) Therapeutic Drink...
Nutraplete Featured in AIDS Institute's Action Link Journal Article
March 04, 2008 09:00 ET
|
Galea Life Sciences
MIAMI, March 4, 2008 (PRIME NEWSWIRE) -- Nutraplete, the flagship product of BioSource Therapeutics (BST), is to be featured in the March 2008 edition of the Action Link Journal. The Action Link...
Galea Life Sciences' BioSource Therapeutics, Inc. Subsidiary Names Edward Martin to its Board of Directors
February 13, 2008 11:16 ET
|
Galea Life Sciences
MIAMI, Feb. 13, 2008 (PRIME NEWSWIRE) -- Galea Life Sciences, Inc. (Pink Sheets:GLSN) announces that its wholly-owned subsidiary, BioSource Therapeutics, Inc. (BST), has named Edward Martin to its...
Galea Life Sciences' BioSource Therapeutics, Inc. Subsidiary Submits Clinical Policy Abstract to 17th International AIDS Conference
February 07, 2008 09:03 ET
|
Galea Life Sciences
MIAMI, Feb. 7, 2008 (PRIME NEWSWIRE) -- Galea Life Sciences, Inc. (Pink Sheets:GLSN) announces that its wholly owned subsidiary, BioSource Therapeutics, Inc. (BST), has submitted its clinical policy...
Dr. Terence M. Dolak, Ph.D. Named Chief Scientific Advisor for Galea Life Sciences' BioSource Therapeutics, Inc. Subsidiary
January 24, 2008 12:06 ET
|
Galea Life Sciences
MIAMI, Jan. 24, 2008 (PRIME NEWSWIRE) -- Galea Life Sciences, Inc. (Pink Sheets:GLSN) announced today that BioSource Therapeutics, Inc. (BST), its wholly-owned subsidiary, has named Dr. Terence M....
Dr. Robert Keller, MD, Named Head of Scientific Advisory Board for Galea Life Sciences' BioSource Therapeutics, Inc. Subsidiary
December 18, 2007 08:17 ET
|
Galea Life Sciences
MIAMI, Dec. 18, 2007 (PRIME NEWSWIRE) -- Galea Life Sciences, Inc. (Pink Sheets:GLSN) announced today that BioSource Therapeutics, Inc. (BST), its wholly-owned subsidiary, has named Dr. Robert Keller,...
Galea Life Sciences, Inc. Retains Hogan & Hartson LLP
December 13, 2007 08:54 ET
|
Galea Life Sciences
MIAMI, Dec. 13, 2007 (PRIME NEWSWIRE) -- Galea Life Sciences, Inc. (Pink sheets:GLSN) today announced that it has retained Hogan & Hartson LLP in connection with obtaining necessary approvals for...
BioSource Therapeutics' CEO David Miller Presents At Global Summit On AIDS and the Church At Saddleback Church
November 30, 2007 11:09 ET
|
Galea Life Sciences
MIAMI, Nov. 30, 2007 (PRIME NEWSWIRE) -- Galea Life Sciences, Inc. (Pink Sheets:GLSN) today announced that David Miller, CEO of its BioSource Therapeutics, Inc. (BST) subsidiary, was a keynote speaker...